| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0018 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |